GABASIGN 800MG

$ 9

Description

GABASIGN 800MG by Signature (Gabapentin) 10 TABLETS X 800 MG – GABAPENTIN 800mg GABASIGN 800MG by Signature is a high‑quality gabapentin formulation — an anticonvulsant and neuropathic pain agent widely used for neuropathic pain, epilepsy, and anxiety management. Manufactured by Signature, a trusted Indian pharmaceutical brand. Buy GABASIGN 800MG online from Steroidify and get pharmaceutical‑grade gabapentin at a competitive price. Why buy GABASIGN 800MG: – Premium gabapentin formulation — manufactured by Signature, a trusted global brand – 800mg per tablet — higher potency for advanced neuropathic pain protocols – Oral administration — convenient, no injections required – Independent lab test — third‑party COA per batch – Buy More & Save — bulk pricing available What it is & how it works Gabapentin is a structural analogue of GABA that works by binding to the alpha‑2‑delta subunit of voltage‑gated calcium channels in the central nervous system. This reduces the release of excitatory neurotransmitters, providing anticonvulsant, analgesic, and anxiolytic effects. It is used for neuropathic pain, partial seizures, and anxiety disorders. Why buy from Steroidify Steroidify is a preferred supplier of Signature. Every tablet is genuine, lab‑verified stock — backed by an independent COA, real Touchdown proof‑of‑delivery photos, and verified‑buyer reviews. Trusted since 2008: authentic product, fully discreet packaging. FAQ Is GABASIGN the same as other gabapentin brands? Yes — the active ingredient is identical. Signature is a reputable, globally recognized pharmaceutical manufacturer. How should I take GABASIGN 800MG? Oral administration — take tablets as directed by your healthcare provider. Dosing frequency and duration should be determined by your specific protocol. How is GABASIGN shipped? Tablets in a sealed blister pack or bottle. Ships discreetly with temperature control.

Reviews

There are no reviews yet.

Be the first to review “GABASIGN 800MG”

Your email address will not be published. Required fields are marked *